Cardinal Capital Management LLC (Connecticut)’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $11.3M | Sell |
|
|||||
|
2024
Q1 | $40.9M | Buy |
|
|||||
|
2023
Q4 | $15.9M | Buy |
|
|||||
|
2023
Q3 | $12.4M | Sell |
|
|||||
|
2023
Q2 | $15.3M | Buy |
|
|||||
|
2023
Q1 | $14.9M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $25.1M | Sell |
|
|||||
|
2021
Q3 | $29.2M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $108M | Buy |
|
|||||
|
2020
Q3 | $89.7M | Buy |
|
|||||
|
2020
Q2 | $97.1M | Sell |
|
|||||
|
2020
Q1 | $71.4M | Buy |
|
|||||
|
2019
Q4 | $95.9M | Buy |
|
|||||
|
2019
Q3 | $88.9M | Sell |
|
|||||
|
2019
Q2 | $102M | Buy |
|
|||||
|
2019
Q1 | $111M | Buy |
|
|||||
|
2018
Q4 | $68.7M | Buy |
|
|||||
|
2018
Q3 | $84.2M | Sell |
|
|||||
|
2018
Q2 | $88.1M | Sell |
|
|||||
|
2018
Q1 | $72.6M | Sell |
|
|||||
|
2017
Q4 | $89.6M | Buy |
|
|||||
|
2017
Q3 | $84.9M | Sell |
|
|||||
|
2017
Q2 | $97.3M | Buy |
|
|||||
|
2017
Q1 | $83.7M | Buy |
|
|||||
|
2016
Q4 | $78M | Buy |
|
|||||
|
2016
Q3 | $68.8M | Buy |
|
|||||
|
2016
Q2 | $79.8M | Sell |
|
|||||
|
2016
Q1 | $89.9M | Sell |
|
|||||
|
2015
Q4 | $92.4M | Sell |
|
|||||
|
2015
Q3 | $75.3M | Sell |
|
|||||
|
2015
Q2 | $101M | Sell |
|
|||||
|
2015
Q1 | $80.4M | Buy |
|
|||||
|
2014
Q4 | $52.5M | Buy |
|
|||||
|
2014
Q3 | $44M | Buy |
|
|||||
|
2014
Q2 | $35.4M | Sell |
|
|||||
|
2014
Q1 | $39.5M | Buy |
|
|||||
|
2013
Q4 | $30.5M | Buy |
|